摘要 : The approval of tisagenlecleucel and axicabtagene ciloleucel in 2017 marked a milestone in the development of oncology therapies. Since 2017, the breakthrough in treatment or even cure of previously intractable diseases represente... 展开
作者 | Shiowjen Lee Poornima Sharma Xue Lin Bindu George John Scott |
---|---|
作者单位 | |
期刊名称 | 《Journal of clinical oncology :》 |
总页数 | 9 |
语种/中图分类号 | 英语 / R73 |
馆藏号 | N2007EPST0002224 |